Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 8,041–8,060 of 17,964 drug recalls

Drug Recall Terminated Historical recordClass II

Testosterone Cypionate Injection, USP, 1000 mg/10 mL (100 mg/mL), For intramuscular use only, 10 mL Vial, Multiple-Dose, Rx Only, Manufactured by: Cipla Ltd., Verna Goa, India, Manufactured for: Cipla USA, Inc., 1560 Sawgrass Corporate Parkway, Suite 130, Sunrise, FL 33323, NDC 69097-536-37.

by InvaGen Pharmaceuticals, Inc.

Reason
Presence of Particulate Matter.
Recall initiated
March 22, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide in the U.S.A.

View recall →

Drug Recall Terminated Historical recordClass II

Testosterone Cypionate Injection, USP, 200 mg/mL, For IM use only, 1 mL Vial, Single Dose, Rx Only, Manufactured by: Cipla Ltd., Verna Goa, India, Manufactured for: Cipla USA, Inc., 1560 Sawgrass Corporate Parkway, Suite 130, Sunrise, FL 33323, NDC 69097-537-31.

by InvaGen Pharmaceuticals, Inc.

Reason
Presence of Particulate Matter.
Recall initiated
March 22, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide in the U.S.A.

View recall →

Drug Recall Terminated Historical recordClass II

Testosterone Cypionate Injection, USP, 2000 mg/10 mL (200 mg/mL), For intramuscular use only, 10 mL Vial, Multiple-Dose, Rx Only, Manufactured by: Cipla Ltd., Verna Goa, India, Manufactured for: Cipla USA, Inc., 1560 Sawgrass Corporate Parkway, Suite 130, Sunrise, FL 33323, NDC 69097-537-37.

by InvaGen Pharmaceuticals, Inc.

Reason
Presence of Particulate Matter.
Recall initiated
March 22, 2019
Reported by FDA
April 24, 2019
Distribution
Nationwide in the U.S.A.

View recall →

Drug Recall Terminated Historical recordClass I

Lidocaine HCl Injection, USP 1 % 50 mg/5 mL (10 mg/mL), 5mL vial, Rx only, Mrd. in India for: AuroMedics Pharna LLC. E Windsor, NJ 08520 NDC 55150-162-05

by Aurobindo Pharma USA Inc.

Reason
Presence of Particulate Matter: One vial was found to contain a hair.
Recall initiated
March 28, 2019
Reported by FDA
April 17, 2019
Distribution
Product is being held at a distributor site in Mexico, Asheboro, NC, Charlotte, NC and Santa Teresa, NM and not further distributed in the U.S. Market.

View recall →

Drug Recall Terminated Historical recordClass I

LEOPARD Miracle Honey packaged in a wooden box, UPC 8 699415 910534, containing 12 sachets 180Gr / 6.36 Oz, each 1 Sachet 15 gr / 0.53 Oz is labeled as LEOPARD Miracle of Honey, UPC 8 699415 912859, Manufactured in Turkey, www leopardhoneytr.com.

by USA LESS Inc.

Reason
Marketed Without An Approved NDA/ANDA: product tainted with undeclared sildenafil, an FDA approved drug for the treatment of male erectile dysfunction. The presence of sildenafil in Leopard Miracle Honey renders it an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall.
Recall initiated
March 5, 2019
Reported by FDA
April 17, 2019
Distribution
Nationwide in the USA.

View recall →

Drug Recall Terminated Historical recordClass III

Thallous Chloride TI 201 Injection, Specific Concentration: 37 MBq/mL (1 mCi/mL), Total Activity: 325.6 MBq (8.8 mCi) Volume: 8.8 mL vial, Rx Only, Mfg. by GE Healthcare, Medi-physics, Inc., Arlington Heights, IL 60004. NDC: 17156-299-18

by Medi-Physics Inc. dba GE Healthcare

Reason
Chemical Contamination: Trace amounts of an impurity was detected in the reagent used to manufacture finished product.
Recall initiated
March 26, 2019
Reported by FDA
April 17, 2019
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

Phenobarbital Oral Solution, USP 20 mg/5mL, unit dose cup, Rx Only, Rpkg. By.Lohxa Worcester, MA 01608 NDC 70166-536-02

by Lohxa LLC

Reason
Labeling: Incorrect or Missing Lot and/or Exp Date - the label contains an incorrect Exp Date.
Recall initiated
March 25, 2019
Reported by FDA
April 17, 2019
Distribution
MA, NY and WY

View recall →

Drug Recall Terminated Historical recordClass II

Bismuth Subsalicylate Oral Suspension 262mg/15mL, unit dose cups, OTC, Rpkg. By.: Lohxa Worcester, MA, NDC 70166-059-01

by Lohxa LLC

Reason
Labeling: Incorrect or Missing Lot and/or Exp Date - the label contains an incorrect Exp Date.
Recall initiated
March 25, 2019
Reported by FDA
April 17, 2019
Distribution
MA, NY and WY

View recall →

Drug Recall Terminated Historical recordClass III

Telmisartan and Amlodipine Tablets 80 mg/5 mg, 30 tablets, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478 --- NDC 42291-795-30

by AVKARE Inc.

Reason
Failed Impurities/Degradation Specifications; 18 month long term stability study (manufacturer)
Recall initiated
April 3, 2019
Reported by FDA
April 17, 2019
Distribution
AZ, CO

View recall →

Drug Recall Terminated Historical recordClass III

Telmisartan and Amlodipine Tablets 80 mg/5 mg, 30 tablet bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD, Manufactured by : Lupin Limited, Goa, INDIA -- NDC 68180-198-06

by Lupin Pharmaceuticals Inc.

Reason
Failed Impurities/Degradation Specifications; 18 month long term stability study.
Recall initiated
April 1, 2019
Reported by FDA
April 17, 2019
Distribution
Product was distributed to 6 wholesalers/ drug chains and 2 mail order pharmacies that may have further distribute the product throughout the United States.

View recall →

Drug Recall Terminated Historical recordClass II

Pravastatin Sodium Tablets USP, 20 mg, 500-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd. Plot No. 2, Phase-2, Pharma zone SEZ, Pithampur, Dist-Dhar, Madhya Pradesh 454 775, India. Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430. NDC 68462-196-05

by Glenmark Pharmaceuticals Inc., USA

Reason
Presence Of Foreign Tablet: in a bottle of Pravastatin Sodium Tablets 20 mg.
Recall initiated
March 25, 2019
Reported by FDA
April 17, 2019
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing Historical recordClass II

Losartan Potassium / Hydrochlorothiazide Tablets, USP 100mg/25mg, a) 30-count (NDC: 13668-118-30), b) 90-count (NDC: 13668-118-90), c) 1000-count (NDC: 13668-118-10) per bottle , Rx only, Manufactured by: Torrent Pharmaceuticals LTD, Indrad-382 721, Dist. Mehsana India. For: Torrent Pharma, Inc, 150 Allen Road, Suite 102, Basking Ridge, NJ

by Torrent Pharma Inc.

Reason
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level.
Recall initiated
February 28, 2019
Reported by FDA
April 17, 2019
Distribution
Nationwide USA and Puerto Rico

View recall →

Drug Recall Ongoing Historical recordClass II

Losartan Potassium / Hydrochlorothiazide Tablets, USP 100mg/12.5mg, a) 30-count (NDC: 13668-117-30), b) 90-count (NDC: 13668-117-90) per bottle , Rx only, Manufactured by: Torrent Pharmaceuticals LTD, Indrad-382 721, Dist. Mehsana India. For: Torrent Pharma, Inc, 150 Allen Road, Suite 102, Basking Ridge, NJ

by Torrent Pharma Inc.

Reason
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level.
Recall initiated
February 28, 2019
Reported by FDA
April 17, 2019
Distribution
Nationwide USA and Puerto Rico

View recall →

Drug Recall Ongoing Historical recordClass II

Losartan Potassium / Hydrochlorothiazide Tablets, USP 50mg/12.5mg, a) 30-count (NDC: 13668-116-30), b) 90-count (NDC: 13668-116-90), c) 1000-count (NDC: 13668-116-10) per bottle , Rx only, Manufactured by: Torrent Pharmaceuticals LTD, Indrad-382 721, Dist. Mehsana India. For: Torrent Pharma, Inc, 150 Allen Road, Suite 102, Basking Ridge, NJ

by Torrent Pharma Inc.

Reason
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level.
Recall initiated
February 28, 2019
Reported by FDA
April 17, 2019
Distribution
Nationwide USA and Puerto Rico

View recall →

Drug Recall Ongoing Historical recordClass II

LOSARTAN POTASSIUM TABLETS, USP, 100 mg, a) 90-count (NDC: 13668-115-90), b) 1000-count (NDC: 13668-115-10), per bottle, Rx only, Manufactured by: Torrent Pharmaceuticals LTD, Indrad-382 721, Dist. Mehsana India. For: Torrent Pharma, Inc, 150 Allen Road, Suite 102, Basking Ridge, NJ

by Torrent Pharma Inc.

Reason
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level.
Recall initiated
February 28, 2019
Reported by FDA
April 17, 2019
Distribution
Nationwide USA and Puerto Rico

View recall →

Drug Recall Ongoing Historical recordClass II

LOSARTAN POTASSIUM TABLETS, USP, 50 mg, a) 30-count (NDC: 13668-409-30), b) 90-count (NDC: 13668-409-90), c) 1000-count (NDC: 13668-409-10), per bottle, Rx only, Manufactured by: Torrent Pharmaceuticals LTD, Indrad-382 721, Dist. Mehsana India. For: Torrent Pharma, Inc, 150 Allen Road, Suite 102, Basking Ridge, NJ

by Torrent Pharma Inc.

Reason
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level.
Recall initiated
February 28, 2019
Reported by FDA
April 17, 2019
Distribution
Nationwide USA and Puerto Rico

View recall →

Drug Recall Ongoing Historical recordClass II

LOSARTAN POTASSIUM TABLETS, USP, 25 mg, a) 90-count (NDC: 13668-113-90), b) 1000-count (NDC: 13668-113-10), per bottle, Rx only, Manufactured by: Torrent Pharmaceuticals LTD, Indrad-382 721, Dist. Mehsana India. For: Torrent Pharma, Inc, 150 Allen Road, Suite 102, Basking Ridge, NJ

by Torrent Pharma Inc.

Reason
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level.
Recall initiated
February 28, 2019
Reported by FDA
April 17, 2019
Distribution
Nationwide USA and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Gavilyte-N, PEG-3350, Sodium chloride, Sodium Bicarbonate and Potassium Chloride for Oral Solution, Rx only, Manufactured by Novel Laboratories, Inc. Somerset, NJ 08873 Manufactured for Lupin Pharmaceuticals, Inc. Baltimore, MD NDC 43386-050-19 UPC 343386050192 a) Lemon Flavor Pack net wt. 2 g UPC 343386200023 b) Orange Flavor Pack net wt. 2 g UPC 343386202027 c) Cherry Flavor Pack net wt. 2 g UPC 3433862034

by LUPIN SOMERSET

Reason
Labeling Not Elsewhere Classified; orange and cherry flavor packets incorrect list "natural lemon flavor" as an ingredient
Recall initiated
March 19, 2019
Reported by FDA
April 17, 2019
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Life-Line tm Catalytic Activated Energy Water, 1 gallon container, McDaniel Life-Line LLC 1775 US Hwy 385 806-647-1741 Dimmitt, TX 79027

by McDaniel Life-Line LLC

Reason
Unapproved new drug
Recall initiated
February 8, 2019
Reported by FDA
April 17, 2019
Distribution
Nationwide, Italy, Australia, Canada, Poland

View recall →

Drug Recall Terminated Historical recordClass II

Indian Herb Paste (a dietary supplement) Ingredients: Galangal, Indian Paint, Yellow Dock & Licorice in an alloy of Life-Line tm and Zinc Chloride in 6 dram vials, McDaniel Life-Line LLC, Dimmitt, TX

by McDaniel Life-Line LLC

Reason
Unapproved new drug
Recall initiated
February 8, 2019
Reported by FDA
April 17, 2019
Distribution
Nationwide, Italy, Australia, Canada, Poland

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.